Hydralyte North America makes a strong debut on ASX
Simon EvansSenior reporter
The parent company selling Hydralyte rehydration tablets and powders in North America made a strong debut on the Australian sharemarket on Tuesday, as it prepares to step up its presence in the United States and Canada by targeting the health and wellness boom.
The company, officially named the Hydration Pharmaceuticals Company, raised $17 million in an initial public offering with an issue price of 29¢.
Loading...
Simon Evans writes on business specialising in retail, manufacturing, beverages, mining and M&A. He is based in Adelaide. Connect with Simon on Twitter. Email Simon at simon.evans@afr.com
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles